JMA Establishes Pharmaceutical Affairs Section to Strengthen Engagement with Generic Drug and Distribution Issues

Kunihiko Suzuki, Executive Member of the Japan Medical Association’s Board of Trustees In an interview with Jiho on August 7, Kunihiko Suzuki, executive member of the Japan Medical Association’s (JMA) Board of Trustees, reported that the JMA’s new Pharmaceutical Affairs...read more